Consumption of submerged aquatic macrophytes by rudd (scardinius erythrophthalmus L.) in New Zealand

In experiments in New Zealand, rudd (Scardinius erythrophthalmus L.) of 108–277mm fork length (FL) ate a wide range of native and introduced submerged aquatic macrophytes in captivity and in the field. Rudd consumed the native charophytes Chara globularis Thuill., Chara fibrosa Ag. ex Bruz., and Nitella spp., the native macrophytes Potamogeton ochreatus Raoul. and Myriophyllum propinquum A. Cunn., and the introduced macrophytes Elodea canadensis Michx., Egeria densa Planch., Lagarosiphon major L., and Ceratophyllum demersum L. Rudd consistently consumed the Nitella spp. and Potamogeton ochreatus before Ceratophyllum demersum. From the results of experiments in tanks and in the field, we found the order of highest to lowest palatability was: Nitella spp. > Potamogeton ochreatus > Elodea canadensis> Chara globularis = Chara fibrosa> Egeria densa = Lagarosiphon major > Myriophyllum propinquum > Ceratophyllum demersum. The order of consumption was subject to some variation with season, especially for Egeria densa, Lagarosiphon major, and Myriophyllum propinquum. Rudd consumed up to 20% of their body weight per day of Egeria densa in spring, and 22% of their body weight per day of Nitella spp. in summer. Consumption rates were considerably lower in winter than in summer. The results of our field trial suggested that the order of consumption also applies in the field and that rudd are having a profound impact on vulnerable native aquatic plant communities in New Zealand. Nitella spp. and Potamogeton ochreatus are likely to be selectively eaten, and herbivory by rudd might prevent the re-establishment of these species in restoration efforts

Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process

The Saccharomyces cerevisiae heat shock protein Hsp31 is a stress-inducible homodimeric protein that is involved in diauxicshift reprogramming and has glyoxalase activity. We show thatsubstoichiometric concentrations of Hsp31 can abrogate aggrega-tion of a broad array of substrates in vitro. Hsp31 also modulates the aggregation of -synuclein ( Syn), a target of the chaperoneactivity of human DJ-1, an Hsp31 homolog. We demonstrate thatHsp31 is able to suppress the in vitro fibrillization or aggregation of Syn, citrate synthase and insulin. Chaperone activity was also observed in vivo because constitutive overexpression of Hsp31 reduced the incidence of Syn cytoplasmic foci, and yeast cells were rescued from Syn-generated proteotoxicity upon Hsp31overexpression. Moreover, we showed that Hsp31 protein levels are increased byH2O2, in the diauxic phase of normal growth con-ditions, and in cells under Syn-mediated proteotoxic stress. Weshow that Hsp31 chaperone activity and not the methylglyoxalaseactivity or the autophagy pathway drives the protective effects.Wealso demonstrate reduced aggregation of the Sup35 prion domain,PrD-Sup35, as visualized by fluorescent protein fusions. In addi-tion, Hsp31 acts on its substrates prior to the formation of largeaggregates because Hsp31 does not mutually localize with prionaggregates, and it prevents the formation of detectable in vitro Syn fibrils. These studies establish that the protective role ofHsp31 against cellular stress is achieved by chaperone activity thatintervenes early in the protein misfolding process and is effectiveona wide spectrum of substrate proteins, including Synandprion proteins

Comparative CPTED Conference

The Sydney Institute of Criminology (University of Sydney) hosted a one-day Comparative CPTED Conference on 24 January 2012. This conference explored recent developments in CPTED practice and theory and brought together an exciting array of academics and practitioners from England, New Zealand, Western Australia, Victoria, Queensland and other locations. National trends and local case studies revealed different approaches and innovative developments in CPTED practice from numerous jurisdictions.SJB Urbi

Conflicts of interest are harming maternal and child health : time for scientific journals to end relationships with manufacturers of breast-milk substitutes

► Forty years after the World Health Assembly adopted the International Code of Marketing of Breast-milk Substitutes, inappropriate marketing of breast-milk substitutes persists and puts infants and young chil- dren at risk of malnutrition, illness and death. ► The formula industry is large and powerful and has used various ‘medical marketing’ strategies to influ- ence scientists and health professionals as to the purported benefit of breast-milk substitutes. ► The examples provided in this commentary show how a manufacturer is using a leading scientific journal to market breast-milk substitutes through paid advertisements and advertisement features. ► By receiving funding from breast-milk substitute manufacturers, journals create a conflict of interest, whereby the publisher and readers of the journal may favour corporations consciously or unconsciously in ways that undermine scientific integrity, editorial in- dependence and clinical judgement. ► Conflicts of interest have previously been identified in infant and young child nutrition science and in journal advertising policies and have been criticised by public health experts, yet the practice continues. ► All scientific journals and publishers should stop ac- cepting funding from manufacturers and distributors of breast-milk substitutes, in accordance with global public health guidance. Public health must come be- fore profit.The DSI/NRF Centre of Excellence in Food Security.https://gh.bmj.comhj2022Paediatrics and Child Healt

Genomic Species Are Ecological Species as Revealed by Comparative Genomics in Agrobacterium tumefaciens

The definition of bacterial species is based on genomic similarities, giving rise to the operational concept of genomic species, but the reasons of the occurrence of differentiated genomic species remain largely unknown. We used the Agrobacterium tumefaciens species complex and particularly the genomic species presently called genomovar G8, which includes the sequenced strain C58, to test the hypothesis of genomic species having specific ecological adaptations possibly involved in the speciation process. We analyzed the gene repertoire specific to G8 to identify potential adaptive genes. By hybridizing 25 strains of A. tumefaciens on DNA microarrays spanning the C58 genome, we highlighted the presence and absence of genes homologous to C58 in the taxon. We found 196 genes specific to genomovar G8 that were mostly clustered into seven genomic islands on the C58 genome—one on the circular chromosome and six on the linear chromosome—suggesting higher plasticity and a major adaptive role of the latter. Clusters encoded putative functional units, four of which had been verified experimentally. The combination of G8-specific functions defines a hypothetical species primary niche for G8 related to commensal interaction with a host plant. This supports that the G8 ancestor was able to exploit a new ecological niche, maybe initiating ecological isolation and thus speciation. Searching genomic data for synapomorphic traits is a powerful way to describe bacterial species. This procedure allowed us to find such phenotypic traits specific to genomovar G8 and thus propose a Latin binomial, Agrobacterium fabrum, for this bona fide genomic species

Governing the Global Land Grab: Multipolarity, Ideas and Complexity in Transnational Governance

Since 2008, a series of new regulatory initiatives have emerged to address large-scale land grabs. These initiatives are occurring simultaneously at multiple levels of social organization instead of a single, overarching institutional site. A significant portion of this activity is taking place at the transnational level. We suggest that transnational land governance is indicative of emerging shifts in the practice of governance of global affairs. We analyze such shifts by asking two related questions: what does land grabbing tell us about developments in transnational governance, particularly with regard to North-South relations, and what do these developments in transnational governance mean for regulating land grabbing?Desde 2008, ha surgido una serie de nuevas iniciativas regulatorias para tratar acaparamientos de tierra a gran escala. Estas iniciativas están sucediendo simultáneamente a niveles múltiples de la organización social en vez de un lugar institucional predominante. Una porción importante de esta actividad está tomando lugar al nivel transnacional. Sugerimos que la gobernanza de tierras trasnacionales es indicativa de los cambios que están surgiendo en la práctica de gobernanza de los asuntos globales. Analizamos tales cambios haciendo dos preguntas relacionadas: ¿qué nos dice el acaparamiento de tierras sobre los desarrollos en la gobernanza trasnacional, particularmente con las relaciones norte-sur?, y ¿qué significan estos desarrollos en gobernanza trasnacional para regular el acaparamiento de tierras

Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission

Abstract Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).</jats:p

Implementation of corticosteroids in treating COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK:prospective observational cohort study

BACKGROUND: Dexamethasone was the first intervention proven to reduce mortality in patients with COVID-19 being treated in hospital. We aimed to evaluate the adoption of corticosteroids in the treatment of COVID-19 in the UK after the RECOVERY trial publication on June 16, 2020, and to identify discrepancies in care. METHODS: We did an audit of clinical implementation of corticosteroids in a prospective, observational, cohort study in 237 UK acute care hospitals between March 16, 2020, and April 14, 2021, restricted to patients aged 18 years or older with proven or high likelihood of COVID-19, who received supplementary oxygen. The primary outcome was administration of dexamethasone, prednisolone, hydrocortisone, or methylprednisolone. This study is registered with ISRCTN, ISRCTN66726260. FINDINGS: Between June 17, 2020, and April 14, 2021, 47 795 (75·2%) of 63 525 of patients on supplementary oxygen received corticosteroids, higher among patients requiring critical care than in those who received ward care (11 185 [86·6%] of 12 909 vs 36 415 [72·4%] of 50 278). Patients 50 years or older were significantly less likely to receive corticosteroids than those younger than 50 years (adjusted odds ratio 0·79 [95% CI 0·70–0·89], p=0·0001, for 70–79 years; 0·52 [0·46–0·58], p80 years), independent of patient demographics and illness severity. 84 (54·2%) of 155 pregnant women received corticosteroids. Rates of corticosteroid administration increased from 27·5% in the week before June 16, 2020, to 75–80% in January, 2021. INTERPRETATION: Implementation of corticosteroids into clinical practice in the UK for patients with COVID-19 has been successful, but not universal. Patients older than 70 years, independent of illness severity, chronic neurological disease, and dementia, were less likely to receive corticosteroids than those who were younger, as were pregnant women. This could reflect appropriate clinical decision making, but the possibility of inequitable access to life-saving care should be considered. FUNDING: UK National Institute for Health Research and UK Medical Research Council